Seattle, WA, United States of America

Impel Neuropharma, Inc.


USPTO Granted Patents = 10


Trademarks = 5

Forward Citations = 31

Loading Chart...
Loading Chart...

12 inventors (with patents filed for the assignee):

goldMedal John D Hoekman (10 out of 21 patents)

silverMedal Alan Brunelle (7 out of 12 patents)

bronzeMedal Michael Hite (5 out of 14 patents)

4.  Joel Relethford (5 out of 7 patents)

5.  Christopher William Fuller (4 out of 9 patents)

6.  Craig Frederick Kohring (3 out of 8 patents)

7.  Kelsey H Satterly (2 out of 5 patents)

8.  Rodney J Y Ho (2 out of 10 patents)

9.  Inna Dashevsky (1 out of 4 patents)

10.  Aditya R Das (1 out of 4 patents)

11.  Scott Youmans (1 out of 11 patents)

12.  Stephen B Shrewsbury (1 out of 8 patents)


10 patents:

Impel Neuropharma, Inc. is a clinical-stage biotechnology company focused on developing innovative therapies for central nervous system (CNS) disorders. The company's proprietary Precision Olfactory Delivery (POD) technology allows for targeted delivery of therapeutics to the brain through the olfactory region, offering potential improvements in efficacy and safety. Impel's pipeline includes treatments for migraine, Parkinson's disease, and other neurological conditions.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

10 Patents

#200 in Seattle, WA

#684 in Washington

#29,828 in US

#55,954 in the World

Seattle, WA (US)
Seattle, WA, United States of America
Forward Citations = 31

12 inventors:

Please report any incorrect information to [email protected]
Loading…